StocksMarket.in

Tag "COVID19"

 Breaking News

: After high hopes for Merck’s COVID-19 pill, Wall Street now expects a ‘tepid’ authorization

It’s likely that Merck’s COVID-19 pill will be authorized in the U.S. this month even though Wall Street’s interest has cooled and physicians have raised questions about the drug’s efficacy

Read Full Article

: A new study finds that most COVID-19 boosters strengthen immunity, though there is no winning shot

The first study directly comparing COVID-19 boosters found that most shots improved immune responses in fully vaccinated people, but there is no obvious “winner” to help make a decision.  “In

Read Full Article

: FDA advisers recommend Merck’s COVID-19 pill in close vote

The Food and Drug Administration advisory committee said Tuesday the benefits of Merck & Co.’s experimental antiviral COVID-19 pill outweigh its risks in a 13-10 vote, with several advisors saying

Read Full Article

The Big Move: My Realtor is isolating after being exposed to COVID-19, but I need to find a new home ASAP. Do I break our business arrangement?

Dear MarketWatch, I live in Fayetteville, N.C., and am currently selling my home and looking to buy another one. My Realtor just told me that his daughter has COVID-19 and he

Read Full Article

Bond Report: Treasury yields post their biggest one-day decline in well over a year amid investor worries about COVID-19 variant

Treasury yields fell sharply in thin trading on Black Friday, posting their biggest one-day declines in well over a year, as investors piled into government debt in a flight to

Read Full Article

Rupee plunges by 37 paise against dollar on new COVID-19 variant worries

Representative image The rupee on November 26 plunged by 37 paise against the US dollar as investors turned cautious in view of massive selloffs in domestic equities and worries over

Read Full Article

ADB approves $1.5 billion loan to India for purchasing COVID-19 vaccines

Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Contact Us | Advertise

Read Full Article

ADB approves $1.5 billion loan to India for purchasing COVID-19 vaccines

“ADB today approved a USD 1.5 billion loan to help the Government of India purchase safe and effective vaccines against

Read Full Article

Key Words: COVID-19 situation is ‘highly dramatic,’ and worse than anything Germany has experienced so far, says Angela Merkel: reports

German Chancellor Angela Merkel is painting a darkening picture for Europe, as a new surge of COVID-19 grips the eurozone’s

Read Full Article

Covid-19 delivers body blow to new hotel projects

Hospitality projects have been delayed, deferred or put on hold across the board. In 2020, just 4,537 keys entered the

Read Full Article

Market Snapshot: Nasdaq rises, Dow falls as U.S. stocks trade mixed amid COVID-19 jitters

U.S. stock indexes were mixed Friday afternoon, with the Dow Jones Industrial Average trading down amid growing concerns over rising

Read Full Article

Bond Report: U.S. Treasury yields fall to lowest in more than a week, as Austria’s COVID-19 lockdown unnerves markets

Yields for U.S. government debt headed sharply lower Friday morning to end the final full week of trading in November

Read Full Article

Coronavirus Update: Europe is the only region where COVID-19 deaths rose in the latest week, as U.S. embarks on effort to greatly boost vaccine manufacturing

Fatalities from the coronavirus-borne illness COVID-19 rose 5% in Europe in the latest week, the World Health Organization said Wednesday,

Read Full Article

Dow Jones Newswires: Celltrion shares rally in South Korea after EU OKs marketing of its COVID-19 treatment

Celltrion Inc.’s shares rallied Monday after the European Commission granted the South Korean biotech firm approval to market its COVID-19

Read Full Article

AstraZeneca says it will start profiting from its COVID-19 vaccine

Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Contact Us | Advertise

Read Full Article

AstraZeneca says it will start profiting from its COVID-19 vaccine

AstraZeneca COVID-19 vaccine (Image: Reuters) Rebecca Robbins and Todd Gregory Drugmaker AstraZeneca has been selling its coronavirus vaccine at not-for-profit

Read Full Article

: ‘As much as we want to move past the virus, we can’t right now’: What a cancelled trip says about our continuing struggle with COVID-19

For the past couple of weeks, I’ve been abuzz about a planned work trip — my first since the start

Read Full Article

Coronavirus Update: U.S. reopens to vaccinated travelers from 33 countries after 18 months, as global tally of COVID-19 cases tops 250 million

The global tally of confirmed cases of the coronavirus-borne illness COVID-19 topped 250 million on Monday, according to data aggregated

Read Full Article

Wall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer

Wall Street’s main indexes scored record closing highs on Friday and booked solid gains for the week following a strong

Read Full Article

Archives